Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Adequacy of care for children with chronic renal insufficiency: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

Adequacy of care for children with chronic renal insufficiency: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Location:

Go back to Resources

Acute rejection probability and severity are declining after pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Go back to Resources

Acute rejection probability and severity are declining after pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Authors:

Location:

Go back to Resources

ABO-mismatched renal transplantation in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB)

Go back to Resources

ABO-mismatched renal transplantation in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Go back to Resources

A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

Authors:

Location:

Go back to Resources

A problem with synthetic maps

Go back to Resources

A problem with synthetic maps

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A meta-analysis of fibromyalgia treatment interventions

Go back to Resources

A meta-analysis of fibromyalgia treatment interventions

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A case-control-study of risk factors for homophiles influenza Type B disease in Navajo children

Go back to Resources

A case-control-study of risk factors for homophiles influenza Type B disease in Navajo children

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

Go back to Resources

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Trends in immunosuppressive therapy: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Go back to Resources

Trends in immunosuppressive therapy: A report of the North American Pediatric Cooperative Study (NAPRTCS)

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

Go back to Resources

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • Current page 118
  • Page 119
  • Page 120
  • Page 121
  • Page 122
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions